Failure of fenoldopam to control severe hypertension secondary to renal graft rejection in a pediatric patient

Military Medicine

Volumn 170, Issue 2, 2005, Pages 130-132

  Lechner, Brent Lee ^a   Pascual, Jose F ^a   Roscelli, John D ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; FENOLDOPAM; FUROSEMIDE; LABETALOL; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PREDNISONE; STEROID; ANTIHYPERTENSIVE AGENT;

ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG MEGADOSE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; MALE; PRESCHOOL CHILD; STEROID THERAPY; TREATMENT FAILURE; GRAFT REJECTION; IMMUNOLOGY; KIDNEY TRANSPLANTATION; RECURRENT DISEASE;

ANTIHYPERTENSIVE AGENTS; CHILD, PRESCHOOL; FENOLDOPAM; GRAFT REJECTION; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; MALE; NITROPRUSSIDE; RECURRENCE; TREATMENT FAILURE;

EID: 17844390137     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Reisen E, Huth MM, Nguyen BP, Weed SG, Gonzalez FM: Intravenous fenoldopam versus sodium nitroprusside in patients with severe hypertension. Hypertension 1990; 15(Suppl 2): 159-62.
2. Tumlin JA, Dunbar LM, Oparil S. et al: Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Acad Emerg Med 2000; 7: 653-62.
3. Tobias JD: Fenoldopam for controlled hypotension during spinal fusion in children and adolescents. Paediatr Anaesth 2000; 10: 261-6.
4. Strauser LM, Pruitt RD, Tobias JD: Initial experience with fenoldopam in children. Am J Ther 1999; 6: 283-8.
5. Panacek EA, Bednarrczyk EM, Dunbar LM, Foulke GE, Holcslaw TL: Randomized, prospective trial of fenoldopam versus sodium nitroprusside in the treatment of acute severe hypertension. Acad Emerg Med 1995; 2: 959-65.
6. Varon J, Marik PE: The diagnosis and management of hypertensive crises. Chest 2000; 118: 214-27.
7. Horn PT, Murphy MB: Therapeutic applications of drugs acting on peripheral dopamine receptors. J Clin Pharmacol 1990; 30: 674-9.
8. Elliott WJ, Weber RR, Nelson KS, et al: Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation 1987; 76: 1312-8.
9. White WB, Halley SE: Comparative renal effects of intravenous administration of fenoldopam and sodium nitroprusside in patients with severe hypertension. Arch Intern Med 1989; 63: 993-6.
10. Post JB, Frishman WH: Fenoldopam: a new dopamine agonist for the treatment of hypertensive urgencies and emergencies. J Clin Pharmacol 1998; 38: 2-13.
11. Mathur VS, Swan SK, Lambrecht LJ, et al: The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 1999; 27: 1832-7.
12. Ligtenberg G, Hene RJ, Blankenestijn PJ, Koomans HA: Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus. J Am Soc Nephrol 2001; 12: 368-73.
13. Jorkasky DK, Audet P, Shusterman N, et al: Fenoldopam reverses cyclosporin-induced renal vasoconstriction in kidney transplant patients. Am J Kidney Dis 1992; 19: 567-72.
14. 2 receptors. Brain Res 1990; 508: 349-52.
15. 2 receptors in human basal ganglia. Brain Res 1999; 843: 136-44.